Medullary Thyroid Cancer (MTC)
5 clinical trials · Condition
◉ Watch Medullary Thyroid Cancer (MTC)
| Record | Firm | Date |
|---|---|---|
| Pembrolizumab in Recurrent or Metastatic Medullary Thyroid Cancer (NCT03072160) | National Cancer Institute (NCI) | 2017-06-16 |
| Nintedanib(BIBF1120) in Thyroid Cancer (NCT01788982) | European Organisation for Research and Treatment of Cancer - EORTC | 2014-05-01 |
| QUILT-3.006 for Recurrent Medullary Thyroid Cancer (NCT01856920) | NantCell, Inc. | 2013-03-26 |
Track Medullary Thyroid Cancer (MTC) automatically
Every clearance here is in the API, with alerts when new ones post.